Last edition
News about "Saroglitazar Mg "
Zydus Completes Enrolment for EPICS IIITM Phase 2b/3 Trial of Saroglitazar Mg
Zydus Lifesciences has completed enrolment of Phase 2b/3 EPICS IIITM trial of Saroglitazar Mg in patients with Primary Biliary Cholangitis (PBC).
Saroglitazar Mg | 10/05/2024 | By Aishwarya | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members